Mosaicism of podocyte involvement is related to podocyte injury in females with Fabry disease - Wikidata - awgldk - TriplyDB

Mosaicism of podocyte involvement is related to podocyte injury in females with Fabry disease

Mosaicism of podocyte involvement is related to podocyte injury in females with Fabry disease

http://www.wikidata.org/entity/Q34489355

about

One Year of Enzyme Replacement Therapy Reduces Globotriaosylceramide Inclusions in Podocytes in Male Adult Patients with Fabry Disease.Urinary Podocyte Loss Is Increased in Patients with Fabry Disease and Correlates with Clinical Severity of Fabry Nephropathy Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study.Podocyturia is significantly elevated in untreated vs treated Fabry adult patients.

P2860

Q35990846-A6B76528-9BA8-4DDF-BE66-4F8386D9CF51 Q36228560-620B08CD-84F1-4535-ADBB-01A1AF065DEC Q39097273-CF510ABB-BB1D-40CA-86E0-F5E2FA5C45A2 Q51751256-13743027-1DB5-476D-A653-3F202480F9AA

P2860

Mosaicism of podocyte involvement is related to podocyte injury in females with Fabry disease

http://www.wikidata.org/entity/Q34489355

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Mosaicism of podocyte involvem ...... in females with Fabry disease

@ast

Mosaicism of podocyte involvem ...... in females with Fabry disease

@en

Mosaicism of podocyte involvem ...... in females with Fabry disease

@nl

type

label

Mosaicism of podocyte involvem ...... in females with Fabry disease

@ast

Mosaicism of podocyte involvem ...... in females with Fabry disease

@en

Mosaicism of podocyte involvem ...... in females with Fabry disease

@nl

prefLabel

Mosaicism of podocyte involvem ...... in females with Fabry disease

@ast

Mosaicism of podocyte involvem ...... in females with Fabry disease

@en

Mosaicism of podocyte involvem ...... in females with Fabry disease

@nl

P1433

Q34489355-ADFB21C5-D563-414A-A019-4CEE242E9138

P1476

Q34489355-51D6CE41-9529-4DE8-9DD9-399301E52B81

P2093

Q34489355-6E5690D7-29EF-4760-84C2-699B00E6623E

Q34489355-6EAE8551-CB5B-4E67-A9DC-D30ADBADA28F

Q34489355-880A15C9-4EDC-42B8-9034-89D18E248753

Q34489355-C96607C0-0AC8-4ECF-B9C7-4D9CCE5C36A6

Q34489355-D6D8C742-2701-4E0E-B72D-7B4DF47EDC65

Q34489355-DD98A205-DC47-47C2-89D3-B288C35C0F7D

Q34489355-DDA01CBA-8636-45E9-B9DF-2C0D07721169

Q34489355-E7C3AC9A-02CA-4BA1-B383-9D4AEB4A0BA3

P2860

Q34489355-09188F52-2FEE-4610-9A03-310C53CD0885

Q34489355-12464C00-1476-4AFF-B774-CFF1BA782415

Q34489355-1D548EBB-7BE9-425E-BD55-FEA5BDC475D1

Q34489355-1D9A595B-C7E2-4023-8143-FE2578AB7CA6

Q34489355-2093FFF2-AADA-4EEB-B6E6-9D38AF237310

Q34489355-2B8F67AA-BD6E-4B78-A5D2-037C082993D8

Q34489355-3555EF4B-2620-412B-9566-DD02B41ED635

Q34489355-367245DE-1C82-484E-A65B-808F66307F73

Q34489355-529E31E2-AE9E-4A46-9C68-853DF846E584

Q34489355-640FFA66-B72A-4466-9DEC-A01680B3756F

P304

Q34489355-25801935-CAAE-4F6D-892C-B6CE8223064D

P31

Q34489355-64845082-CA04-41E7-98C0-3D91DE2955E0

P356

Q34489355-2911C27D-E70F-490B-8C69-0DEB1ADACBE9

P407

Q34489355-1A776C71-9157-46AF-94B1-CBA3594C5C2A

P433

Q34489355-DDC3040C-DA9A-4E63-B1FD-4B26F7548CCE

P478

Q34489355-E2B59C91-BEE8-40CC-9F12-539DB04E21CE

P50

Q34489355-49F5A193-038F-4EB0-83E6-E25C57132D6E

P577

Q34489355-E2AC6E87-B266-42B3-B67D-75D62123F3DB

P5875

Q34489355-F96574AB-B84E-48BF-A647-FD82EEA3D724

P698

Q34489355-01E98B63-18D6-40C1-85A2-B13309A8C364

P932

Q34489355-DBD444E7-6D39-47E0-8683-C61F66437C42

P356

JOURNAL.PONE.0112188

P1433

P1476

Mosaicism of podocyte involvem ...... in females with Fabry disease

@en

P2093

Alexey Sokolovskiy

http://www.w3.org/2001/XMLSchema#string

Behzad Najafian

http://www.w3.org/2001/XMLSchema#string

Camilla Tøndel

http://www.w3.org/2001/XMLSchema#string

Chester Whitley

http://www.w3.org/2001/XMLSchema#string

Einar Svarstad

http://www.w3.org/2001/XMLSchema#string

Emily Glynn

http://www.w3.org/2001/XMLSchema#string

Michael Mauer

http://www.w3.org/2001/XMLSchema#string

Michael West

http://www.w3.org/2001/XMLSchema#string

P2860

Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey

Podocyte biology and pathogenesis of kidney disease

Expression of the disease on female carriers of X-linked lysosomal disorders: a brief review.

Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease.

Quantitating glomerular endothelial fenestration: an unbiased stereological approach.

Podocyte injury damages other podocytes.

Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation.

Pathways to nephron loss starting from glomerular diseases-insights from animal models.

From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy.

Fabry disease: thirty-five mutations in the alpha-galactosidase A gene in patients with classic and variant phenotypes.

P304

e112188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0112188

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Marie-Claire Gubler

P577

2014-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268229010

http://www.w3.org/2001/XMLSchema#string

P698

25386848

http://www.w3.org/2001/XMLSchema#string

P932

4227696

http://www.w3.org/2001/XMLSchema#string